| Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations L Pagano, A Busca, A Candoni, C Cattaneo, S Cesaro, R Fanci, G Nadali, ... Blood reviews 31 (2), 17-29, 2017 | 191 | 2017 |
| Extracellular vesicle microRNAs contribute to the osteogenic inhibition of mesenchymal stem cells in multiple myeloma S Raimondo, O Urzì, A Conigliaro, G Lo Bosco, S Parisi, M Carlisi, ... Cancers 12 (2), 449, 2020 | 56 | 2020 |
| Immunosenescence and lymphomagenesis S Mancuso, M Carlisi, M Santoro, M Napolitano, S Raso, S Siragusa Immunity & Ageing 15, 1-7, 2018 | 46 | 2018 |
| The essential thrombocythemia in 2020: what we know and where we still have to dig deep V Accurso, M Santoro, S Mancuso, M Napolitano, M Carlisi, M Mattana, ... Clinical Medicine Insights: Blood Disorders 13, 2634853520978210, 2020 | 43 | 2020 |
| Feasibility, tolerability and efficacy of carfilzomib in combination with lenalidomide and dexamethasone in relapsed refractory myeloma patients: a retrospective real-life … C Conticello, A Romano, V Del Fabro, EA Martino, V Calafiore, ... Journal of clinical medicine 8 (6), 877, 2019 | 24 | 2019 |
| Lymphomas and thyroid: Bridging the gap S Mancuso, M Carlisi, M Napolitano, S Siragusa Hematological oncology 36 (3), 519-524, 2018 | 19 | 2018 |
| Hemorheological parameters in monoclonal gammopathy of undetermined significance (MGUS) G Caimi, E Hopps, M Carlisi, M Montana, E Gallà, R Lo Presti, S Siragusa Clinical Hemorheology and Microcirculation 68 (1), 51-59, 2018 | 15 | 2018 |
| Cardio-oncology in multiple myeloma: is it time for a specific focus? S Mancuso, M Carlisi, M Sarocchi, M Napolitano, S Siragusa Leukemia & lymphoma 59 (7), 1764-1766, 2018 | 12 | 2018 |
| Paroxysmal nocturnal hemoglobinuria: When delay in diagnosis and long therapy occurs S Mancuso, G Sucato, M Carlisi, M Santoro, G Tarantino, E Iannitto, ... Hematology Reports 10 (1), 7523, 2018 | 11 | 2018 |
| Erythrocyte deformability and hemorheological profile in multiple myeloma G Caimi, M Carlisi, M Montana, E Gallà, R Lo Presti, E Hopps, S Siragusa Clinical Hemorheology and Microcirculation 68 (1), 25-34, 2018 | 11 | 2018 |
| Clinical disorders responsible for plasma hyperviscosity and skin complications G Caimi, M Carlisi, C Urso, RL Presti, E Hopps European journal of internal medicine 42, 24-28, 2017 | 11 | 2017 |
| Host‐related factors and cancer: Malnutrition and non‐Hodgkin lymphoma S Mancuso, M Mattana, M Santoro, M Carlisi, S Buscemi, S Siragusa Hematological Oncology 40 (3), 320-331, 2022 | 10 | 2022 |
| Effects of B-cell lymphoma on the immune system and immune recovery after treatment: the paradigm of targeted therapy S Mancuso, M Mattana, M Carlisi, M Santoro, S Siragusa International Journal of Molecular Sciences 23 (6), 3368, 2022 | 10 | 2022 |
| Comparison between thrombotic risk scores in essential thrombocythemia and survival implications M Santoro, V Accurso, S Mancuso, M Carlisi, S Raso, G Tarantino, ... Hematological Oncology 37 (4), 434-437, 2019 | 10 | 2019 |
| High output heart failure in multiple myeloma: pathogenetic considerations M Carlisi, S Mancuso, R Lo Presti, S Siragusa, G Caimi Cancers 14 (3), 610, 2022 | 9 | 2022 |
| Red blood cell deformability in multiple myeloma G Caimi, M Carlisi, M Montana, E Gallà, E Hopps, R Lo Presti, S Siragusa Clinical Hemorheology and Microcirculation 69 (1-2), 233-238, 2018 | 8 | 2018 |
| Reflections on the unexpected laboratory finding of hemorheological alterations observed in some haematological disorders G Caimi, RL Presti, M Carlisi Microvascular Research 136, 104171, 2021 | 7 | 2021 |
| An assessment of the hemorheological profile in patients with subclinical carotid atherosclerosis divided in relation to the number of cardiovascular risk factors and different … G Caimi, C Urso, S Brucculeri, C Amato, M Carlisi, R Lo Presti Clinical Hemorheology and Microcirculation 78 (4), 417-428, 2021 | 7 | 2021 |
| Network meta‐analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplant C Botta, E Gigliotta, B Paiva, R Anselmo, M Santoro, PR Otero, M Carlisi, ... Hematological Oncology 40 (5), 987-998, 2022 | 6 | 2022 |
| Late onset of unilateral optic disk edema secondary to treatment with imatinib mesylate M Napolitano, M Santoro, S Mancuso, M Carlisi, S Raso, G Tarantino, ... Clinical Case Reports 5 (10), 1573, 2017 | 6 | 2017 |
